Related Experiment Videos
Trisomy 10 in acute myeloid leukemia: three new cases
I E Llewellyn1, C M Morris, S Stanworth
1Canterbury Health Laboratories, Christchurch, New Zealand.
Cancer Genetics and Cytogenetics
|April 5, 2000
Summary
Trisomy 10 is a rare genetic abnormality linked to acute myeloid leukemia (AML). This study clarifies the hematological and clinical features of trisomy 10 in AML by reviewing existing cases and adding new ones.
Area of Science:
- Hematology
- Cytogenetics
- Oncology
Background:
- Trisomy 10 is a rare nonrandom cytogenetic abnormality.
- Its association with acute myeloid leukemia (AML) is infrequent.
- The clinical and hematological characteristics of trisomy 10 in AML require further definition.
Observation:
- A literature review identified 13 cases of trisomy 10 in AML.
- Some cases were reported as a minor component in broader AML studies.
- Detailed clinical and hematological data were often lacking in previous reports.
Findings:
- This study summarizes 13 previously reported cases of trisomy 10 in AML.
- Three new cases of trisomy 10 in AML are presented.
- The combined data aim to provide a clearer picture of this rare AML subtype.
Implications:
- Enhanced understanding of trisomy 10 in AML can aid in diagnosis.
- Defining specific features may lead to tailored treatment strategies.
- Further research is warranted to fully elucidate the impact of trisomy 10 on AML prognosis.